Back to funds

Remedium Capital Partners, LLC

hedge fundUpdated 9 days ago

Managed by Remedium Capital Partners, Llc • Latest filing Q3 2026

Portfolio value
$273.6M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$170.2M
Q1 2026$319.8M
Q2 2026$451.6M
Q3 2026$273.6M

Top holdings

6 positions as of Q3 2026

View filing
S

Spyre Therapeutics Inc

Value
$103.3M
Shares
1.16M
% Port
37.77%
O

Oruka Therapeutics Inc

Value
$79.5M
Shares
954.1K
% Port
29.05%
?
3.N/A

Damora Therapeutics Inc

Value
$43.5M
Shares
2.05M
% Port
15.91%
J

Jade Biosciences Inc

Value
$25.4M
Shares
1.81M
% Port
9.28%
K

Korsana Biosciences Inc

Value
$16.6M
Shares
518.5K
% Port
6.06%
C

Crescent Biopharma Inc

Value
$5.3M
Shares
361.3K
% Port
1.93%

Explore